CN Stock MarketDetailed Quotes

603520 Zhejiang Starry Pharmaceutical

Watchlist
  • 12.57
  • +0.19+1.53%
Market Closed Apr 30 15:00 CST
4.31BMarket Cap91.75P/E (TTM)

Zhejiang Starry Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
13.50%642.3M
3.04%2.2B
18.43%1.63B
15.00%1.08B
9.40%565.91M
6.57%2.13B
5.07%1.38B
10.22%942.47M
42.08%517.3M
46.29%2B
Operating revenue
13.50%642.3M
3.04%2.2B
18.43%1.63B
15.00%1.08B
9.40%565.91M
6.57%2.13B
5.07%1.38B
10.22%942.47M
42.08%517.3M
46.29%2B
Other operating revenue
----
-23.98%200.4M
----
-1.08%133.12M
----
108.06%263.61M
----
443.74%134.57M
----
1,026.74%126.7M
Total operating cost
12.28%623.18M
2.06%2.14B
14.67%1.59B
17.11%1.05B
25.53%555.02M
29.84%2.1B
33.33%1.39B
36.31%900.29M
51.43%442.15M
48.67%1.61B
Operating cost
11.06%499.54M
2.71%1.66B
20.98%1.23B
24.29%828.49M
26.55%449.8M
29.30%1.62B
30.06%1.02B
36.17%666.59M
75.12%355.45M
63.50%1.25B
Operating tax surcharges
-13.06%4.72M
26.74%18.45M
26.11%14.6M
26.63%10.72M
2.30%5.43M
-6.36%14.56M
-0.97%11.58M
12.31%8.46M
40.38%5.31M
18.77%15.55M
Operating expense
34.90%25.57M
39.98%99.13M
13.60%64.27M
18.29%42M
221.76%18.95M
259.88%70.81M
421.02%56.57M
364.64%35.5M
106.95%5.89M
102.53%19.68M
Administration expense
17.78%30.4M
-12.11%127.87M
-14.05%91.38M
-13.96%60.58M
-26.49%25.81M
11.15%145.49M
10.54%106.32M
1.91%70.42M
15.49%35.11M
-6.78%130.89M
Financial expense
52.75%30.82M
-15.20%96.49M
-14.22%84.92M
-17.71%47.36M
62.43%20.18M
58.61%113.79M
73.23%98.99M
70.87%57.55M
-54.30%12.42M
3.85%71.74M
-Interest expense (Financial expense)
3.95%26.91M
10.80%102.6M
23.97%79.29M
23.75%50.07M
70.69%25.89M
25.44%92.6M
10.04%63.96M
8.97%40.46M
-20.96%15.17M
-19.79%73.82M
-Interest Income (Financial expense)
-9.35%-2.31M
22.17%-7.55M
26.36%-5.34M
44.18%-3.92M
-111.00%-2.12M
-70.06%-9.7M
-36.54%-7.25M
-83.55%-7.02M
51.13%-1M
-45.59%-5.7M
Research and development
-7.81%32.12M
1.47%134.56M
8.46%103.55M
5.50%65.17M
24.58%34.84M
6.44%132.61M
17.06%95.47M
16.52%61.77M
12.72%27.97M
41.82%124.58M
Credit Impairment Loss
-125.31%-5.2M
1,289.31%8.9M
82.95%4.2M
201.32%3.49M
62.58%-2.31M
92.13%-747.97K
123.74%2.3M
43.47%-3.45M
-96.66%-6.17M
-165.80%-9.51M
Asset Impairment Loss
-239.47%-1.86M
76.34%-29.48M
-1,743.26%-10.28M
-1,010.59%-6.71M
---546.77K
-3,834.39%-124.61M
79.05%-557.86K
33.40%-604.08K
----
-101.99%-3.17M
Other net revenue
131.65%312.71K
91.61%-7.63M
-89.79%5.65M
-87.92%5.42M
-105.36%-987.96K
-739.36%-90.98M
631.00%55.38M
541.65%44.9M
135.07%18.42M
11.91%14.23M
Fair value change income
94.97%-23.15K
-97.36%23.15K
----
----
---460.54K
453.18%876.69K
9.94%1.06M
-98.14%17.22K
----
-79.14%158.48K
Invest income
-259.01%-4.58M
-229.22%-14.13M
-118.00%-5.12M
-113.27%-3.79M
-110.36%-1.28M
51.22%10.93M
401.30%28.44M
910.21%28.55M
936.80%12.32M
137.24%7.23M
-Including: Investment income associates
-20.87%-1.2M
-505.29%-9.98M
-13,810.97%-4.8M
-3,008.29%-3.05M
-913.65%-993.16K
-189.94%-1.65M
-103.22%-34.49K
-111.45%-97.98K
-122.96%-97.98K
-11.08%1.83M
Asset deal income
986.79%261.33K
1,121.09%3.53M
-19.92%3.66M
-23.89%3.48M
-99.44%24.05K
89.64%-345.94K
262.08%4.57M
318.59%4.57M
3,649.63%4.28M
-256.48%-3.34M
Other revenue
227.17%11.71M
2.65%23.53M
-32.59%13.19M
-43.42%8.95M
-55.23%3.58M
0.28%22.92M
21.52%19.57M
28.11%15.82M
-13.44%8M
52.47%22.85M
Operating profit
96.28%19.43M
188.17%49.19M
0.60%43.52M
-59.81%35M
-89.42%9.9M
-113.96%-55.79M
-84.34%43.26M
-56.81%87.08M
17.07%93.57M
36.00%399.77M
Add:Non operating Income
1,830.20%298.31K
-79.95%204.35K
-69.62%179.87K
-71.02%139.9K
-87.77%15.46K
-50.32%1.02M
7.38%592.04K
19.61%482.7K
-67.57%126.4K
-86.74%2.05M
Less:Non operating expense
445.09%1.18M
-61.98%4.04M
-60.06%2.38M
-58.56%1.87M
-84.35%216.12K
65.50%10.63M
31.77%5.96M
22.93%4.5M
36.60%1.38M
12.42%6.43M
Total profit
91.27%18.55M
169.34%45.35M
9.04%41.32M
-59.94%33.27M
-89.49%9.7M
-116.54%-65.4M
-86.09%37.9M
-58.13%83.06M
16.41%92.32M
30.19%395.39M
Less:Income tax cost
1,501.14%5.99M
-87.76%798.82K
-79.13%1.82M
-114.51%-2M
-93.43%374.24K
-90.06%6.53M
-83.73%8.74M
-69.82%13.77M
-61.24%5.7M
30.98%65.62M
Net profit
34.69%12.56M
FLtoP44.55M
35.48%39.5M
-49.10%35.27M
-89.23%9.33M
SL-71.93M
-86.67%29.15M
-54.64%69.29M
34.08%86.62M
30.04%329.77M
Net profit from continuing operation
34.69%12.56M
161.94%44.55M
35.48%39.5M
-49.10%35.27M
-89.23%9.33M
-121.81%-71.93M
-86.67%29.15M
-54.64%69.29M
34.08%86.62M
30.04%329.77M
Less:Minority Profit
215.22%278.73K
-91.80%321.26K
-98.14%178.81K
-100.11%-5.64K
-103.79%-241.92K
-34.82%3.92M
1,211.22%9.61M
278.94%5.21M
18,332.97%6.38M
-59.55%6.01M
Net profit of parent company owners
28.37%12.28M
158.32%44.23M
101.17%39.32M
-44.95%35.28M
-88.08%9.57M
-123.43%-75.85M
-91.10%19.54M
-58.83%64.08M
24.27%80.24M
35.62%323.75M
Earning per share
Basic earning per share
33.33%0.04
159.09%0.13
83.33%0.11
-47.37%0.1
-87.50%0.03
-123.40%-0.22
-90.63%0.06
-58.70%0.19
-7.69%0.24
-6.00%0.94
Diluted earning per share
33.33%0.04
159.09%0.13
83.33%0.11
-47.37%0.1
-87.50%0.03
-123.16%-0.22
-90.63%0.06
-58.70%0.19
-7.69%0.24
-5.00%0.95
Other composite income
-912.79%-1.93M
-206.44%-9.84M
-70.68%3.07M
68.15%8.03M
108.17%237.87K
392.20%9.25M
814.76%10.47M
322.97%4.78M
-234.19%-2.91M
-810.04%-3.16M
Other composite income of parent company owners
-912.79%-1.93M
-206.44%-9.84M
-70.68%3.07M
68.15%8.03M
108.17%237.87K
392.20%9.25M
814.76%10.47M
322.97%4.78M
-234.19%-2.91M
-732.79%-3.16M
Total composite income
11.13%10.63M
155.37%34.71M
7.43%42.57M
-41.54%43.3M
-88.58%9.56M
-119.19%-62.68M
-81.75%39.62M
-50.82%74.06M
31.34%83.71M
28.97%326.6M
Total composite income of parent company owners
5.54%10.35M
151.63%34.39M
41.22%42.39M
-37.11%43.31M
-87.32%9.81M
-120.77%-66.6M
-86.23%30.01M
-55.14%68.86M
21.39%77.33M
34.50%320.59M
Total composite income of minority owners
215.22%278.73K
-91.80%321.26K
-98.14%178.81K
-100.11%-5.64K
-103.79%-241.92K
-34.82%3.92M
1,211.22%9.61M
278.94%5.21M
18,332.97%6.38M
-59.64%6.01M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 13.50%642.3M3.04%2.2B18.43%1.63B15.00%1.08B9.40%565.91M6.57%2.13B5.07%1.38B10.22%942.47M42.08%517.3M46.29%2B
Operating revenue 13.50%642.3M3.04%2.2B18.43%1.63B15.00%1.08B9.40%565.91M6.57%2.13B5.07%1.38B10.22%942.47M42.08%517.3M46.29%2B
Other operating revenue -----23.98%200.4M-----1.08%133.12M----108.06%263.61M----443.74%134.57M----1,026.74%126.7M
Total operating cost 12.28%623.18M2.06%2.14B14.67%1.59B17.11%1.05B25.53%555.02M29.84%2.1B33.33%1.39B36.31%900.29M51.43%442.15M48.67%1.61B
Operating cost 11.06%499.54M2.71%1.66B20.98%1.23B24.29%828.49M26.55%449.8M29.30%1.62B30.06%1.02B36.17%666.59M75.12%355.45M63.50%1.25B
Operating tax surcharges -13.06%4.72M26.74%18.45M26.11%14.6M26.63%10.72M2.30%5.43M-6.36%14.56M-0.97%11.58M12.31%8.46M40.38%5.31M18.77%15.55M
Operating expense 34.90%25.57M39.98%99.13M13.60%64.27M18.29%42M221.76%18.95M259.88%70.81M421.02%56.57M364.64%35.5M106.95%5.89M102.53%19.68M
Administration expense 17.78%30.4M-12.11%127.87M-14.05%91.38M-13.96%60.58M-26.49%25.81M11.15%145.49M10.54%106.32M1.91%70.42M15.49%35.11M-6.78%130.89M
Financial expense 52.75%30.82M-15.20%96.49M-14.22%84.92M-17.71%47.36M62.43%20.18M58.61%113.79M73.23%98.99M70.87%57.55M-54.30%12.42M3.85%71.74M
-Interest expense (Financial expense) 3.95%26.91M10.80%102.6M23.97%79.29M23.75%50.07M70.69%25.89M25.44%92.6M10.04%63.96M8.97%40.46M-20.96%15.17M-19.79%73.82M
-Interest Income (Financial expense) -9.35%-2.31M22.17%-7.55M26.36%-5.34M44.18%-3.92M-111.00%-2.12M-70.06%-9.7M-36.54%-7.25M-83.55%-7.02M51.13%-1M-45.59%-5.7M
Research and development -7.81%32.12M1.47%134.56M8.46%103.55M5.50%65.17M24.58%34.84M6.44%132.61M17.06%95.47M16.52%61.77M12.72%27.97M41.82%124.58M
Credit Impairment Loss -125.31%-5.2M1,289.31%8.9M82.95%4.2M201.32%3.49M62.58%-2.31M92.13%-747.97K123.74%2.3M43.47%-3.45M-96.66%-6.17M-165.80%-9.51M
Asset Impairment Loss -239.47%-1.86M76.34%-29.48M-1,743.26%-10.28M-1,010.59%-6.71M---546.77K-3,834.39%-124.61M79.05%-557.86K33.40%-604.08K-----101.99%-3.17M
Other net revenue 131.65%312.71K91.61%-7.63M-89.79%5.65M-87.92%5.42M-105.36%-987.96K-739.36%-90.98M631.00%55.38M541.65%44.9M135.07%18.42M11.91%14.23M
Fair value change income 94.97%-23.15K-97.36%23.15K-----------460.54K453.18%876.69K9.94%1.06M-98.14%17.22K-----79.14%158.48K
Invest income -259.01%-4.58M-229.22%-14.13M-118.00%-5.12M-113.27%-3.79M-110.36%-1.28M51.22%10.93M401.30%28.44M910.21%28.55M936.80%12.32M137.24%7.23M
-Including: Investment income associates -20.87%-1.2M-505.29%-9.98M-13,810.97%-4.8M-3,008.29%-3.05M-913.65%-993.16K-189.94%-1.65M-103.22%-34.49K-111.45%-97.98K-122.96%-97.98K-11.08%1.83M
Asset deal income 986.79%261.33K1,121.09%3.53M-19.92%3.66M-23.89%3.48M-99.44%24.05K89.64%-345.94K262.08%4.57M318.59%4.57M3,649.63%4.28M-256.48%-3.34M
Other revenue 227.17%11.71M2.65%23.53M-32.59%13.19M-43.42%8.95M-55.23%3.58M0.28%22.92M21.52%19.57M28.11%15.82M-13.44%8M52.47%22.85M
Operating profit 96.28%19.43M188.17%49.19M0.60%43.52M-59.81%35M-89.42%9.9M-113.96%-55.79M-84.34%43.26M-56.81%87.08M17.07%93.57M36.00%399.77M
Add:Non operating Income 1,830.20%298.31K-79.95%204.35K-69.62%179.87K-71.02%139.9K-87.77%15.46K-50.32%1.02M7.38%592.04K19.61%482.7K-67.57%126.4K-86.74%2.05M
Less:Non operating expense 445.09%1.18M-61.98%4.04M-60.06%2.38M-58.56%1.87M-84.35%216.12K65.50%10.63M31.77%5.96M22.93%4.5M36.60%1.38M12.42%6.43M
Total profit 91.27%18.55M169.34%45.35M9.04%41.32M-59.94%33.27M-89.49%9.7M-116.54%-65.4M-86.09%37.9M-58.13%83.06M16.41%92.32M30.19%395.39M
Less:Income tax cost 1,501.14%5.99M-87.76%798.82K-79.13%1.82M-114.51%-2M-93.43%374.24K-90.06%6.53M-83.73%8.74M-69.82%13.77M-61.24%5.7M30.98%65.62M
Net profit 34.69%12.56MFLtoP44.55M35.48%39.5M-49.10%35.27M-89.23%9.33MSL-71.93M-86.67%29.15M-54.64%69.29M34.08%86.62M30.04%329.77M
Net profit from continuing operation 34.69%12.56M161.94%44.55M35.48%39.5M-49.10%35.27M-89.23%9.33M-121.81%-71.93M-86.67%29.15M-54.64%69.29M34.08%86.62M30.04%329.77M
Less:Minority Profit 215.22%278.73K-91.80%321.26K-98.14%178.81K-100.11%-5.64K-103.79%-241.92K-34.82%3.92M1,211.22%9.61M278.94%5.21M18,332.97%6.38M-59.55%6.01M
Net profit of parent company owners 28.37%12.28M158.32%44.23M101.17%39.32M-44.95%35.28M-88.08%9.57M-123.43%-75.85M-91.10%19.54M-58.83%64.08M24.27%80.24M35.62%323.75M
Earning per share
Basic earning per share 33.33%0.04159.09%0.1383.33%0.11-47.37%0.1-87.50%0.03-123.40%-0.22-90.63%0.06-58.70%0.19-7.69%0.24-6.00%0.94
Diluted earning per share 33.33%0.04159.09%0.1383.33%0.11-47.37%0.1-87.50%0.03-123.16%-0.22-90.63%0.06-58.70%0.19-7.69%0.24-5.00%0.95
Other composite income -912.79%-1.93M-206.44%-9.84M-70.68%3.07M68.15%8.03M108.17%237.87K392.20%9.25M814.76%10.47M322.97%4.78M-234.19%-2.91M-810.04%-3.16M
Other composite income of parent company owners -912.79%-1.93M-206.44%-9.84M-70.68%3.07M68.15%8.03M108.17%237.87K392.20%9.25M814.76%10.47M322.97%4.78M-234.19%-2.91M-732.79%-3.16M
Total composite income 11.13%10.63M155.37%34.71M7.43%42.57M-41.54%43.3M-88.58%9.56M-119.19%-62.68M-81.75%39.62M-50.82%74.06M31.34%83.71M28.97%326.6M
Total composite income of parent company owners 5.54%10.35M151.63%34.39M41.22%42.39M-37.11%43.31M-87.32%9.81M-120.77%-66.6M-86.23%30.01M-55.14%68.86M21.39%77.33M34.50%320.59M
Total composite income of minority owners 215.22%278.73K-91.80%321.26K-98.14%178.81K-100.11%-5.64K-103.79%-241.92K-34.82%3.92M1,211.22%9.61M278.94%5.21M18,332.97%6.38M-59.64%6.01M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg